Literature DB >> 8031964

Thyroglobulin is a more sensitive indicator of iodine deficiency than thyrotropin: development and evaluation of dry blood spot assays for thyrotropin and thyroglobulin in iodine-deficient geographical areas.

U Missler1, R Gutekunst, W G Wood.   

Abstract

Immunometric assays were developed for thyrotropin and thyroglobulin using time-resolved fluorescence as the measurement signal. The assays were suitable for measurements in serum/plasma or in dry blood spots (3 mm diameter). Both assays have acceptable coefficients of variation for dry blood spots (intra-assay median CV < 10%, interassay CV < 15%) in the concentration range of interest (thyrotropin 3-250 mU/l, thyroglobulin 10-500 micrograms/l). The relatively high CV values are not only due to the assay design but also the inhomogeneity of the samples used. For serum samples the median intra-assay CV was < 3% for thyrotropin in the range 0.1-50 mU/l and for thyroglobulin between 2 and 500 micrograms/l. The corresponding inter-assay CV were less than 5%. The assays were evaluated in field studies carried out under auspices of International Council for Control of Iodine Deficiency Disorders (ICCIDD) with the support of UNICEF in Algeria, Peru, India and Zimbabwe, and were found to be practical inasmuch as dry blood spot samples could be transported without special precautions for up to 5-6 weeks without significant loss in immunoreactivity. This agrees with other findings. The results showed that serum thyroglobulin levels are a more sensitive indicator of iodine deficiency than thyrotropin; elevated thyroglobulin levels were found in 182/304 children in Zimbabwe compared with elevated thyrotropin level in 28/304 cases. 213/304 children had enlarged thyroid glands. The cut-off levels used here were 4.5 mU/l thyrotropin and 20 micrograms/l for thyroglobulin, both in whole blood. The assays proved useful for assessing the efficacy of iodine therapy, either by oral dosage or intramuscularly (iodised oil).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8031964     DOI: 10.1515/cclm.1994.32.3.137

Source DB:  PubMed          Journal:  Eur J Clin Chem Clin Biochem        ISSN: 0939-4974


  6 in total

1.  Serum thyroglobulin, a biomarker for iodine deficiency, is not associated with increased risk of upper gastrointestinal cancers in a large Chinese cohort.

Authors:  Shih-Wen Lin; Jin-Hu Fan; Sanford M Dawsey; Philip R Taylor; You-Lin Qiao; Christian C Abnet
Journal:  Int J Cancer       Date:  2011-06-29       Impact factor: 7.396

2.  Iodine status remains critical in mother and infant in Central Anatolia (Kayseri) of Turkey.

Authors:  Selim Kurtoglu; Mustafa Akcakus; Celebi Kocaoglu; Tamer Gunes; Nurten Budak; Mehmet Emre Atabek; Inci Karakucuk; François Delange
Journal:  Eur J Nutr       Date:  2004-01-30       Impact factor: 5.614

3.  Factors associated with serum thyroglobulin levels in a population living in Belarus.

Authors:  Elizabeth K Cahoon; Alexander Rozhko; Maureen Hatch; Olga Polyanskaya; Evgenia Ostroumova; Min Tang; Eldar Nadirov; Vasilina Yauseyenka; Irina Savasteeva; Robert J McConnell; Ruth M Pfeiffer; Alina V Brenner
Journal:  Clin Endocrinol (Oxf)       Date:  2013-04-27       Impact factor: 3.478

4.  Levothyroxine treatment in pregnancy: indications, efficacy, and therapeutic regimen.

Authors:  Joanna Klubo-Gwiezdzinska; Kenneth D Burman; Douglas Van Nostrand; Leonard Wartofsky
Journal:  J Thyroid Res       Date:  2011-08-25

5.  Thyroglobulin level at week 16 of pregnancy is superior to urinary iodine concentration in revealing preconceptual and first trimester iodine supply.

Authors:  Monika Katko; Andrea Anett Gazso; Ildiko Hircsu; Harjit Pal Bhattoa; Zsuzsanna Molnar; Bela Kovacs; David Andrasi; Janos Aranyosi; Rita Makai; Lajos Veress; Olga Torok; Miklos Bodor; Laszlo Samson; Endre V Nagy
Journal:  Matern Child Nutr       Date:  2017-06-07       Impact factor: 3.092

6.  Assessment of iodine status in children, adults, pregnant women and lactating women in iodine-replete areas of China.

Authors:  Fangang Meng; Rencheng Zhao; Peng Liu; Lixiang Liu; Shoujun Liu
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.